title: Mechanisms for induction of immunosuppression during experimental cryptococcosis: role of glucuronoxylomannan.
abstract: In previous work we have demonstrated that spleen mononuclear (Spm) cells from rats obtained 14 days after infection with Cryptococcus neoformans showed a diminution in proliferative response to Concanavalin A (Con A). In this study we further investigate some characteristics of the Spm cell population involved in the immunosuppressor phenomenon induced by C. neoformans. We observed that unstimulated Spm cells expressing T-cell receptor (TCR+) from infected rats were reduced in number after 96 h of culture. When the Spm cells from infected rats were stimulated with Con A, increased production of IL-10, reduced levels of IL-2, and decreased CD11a surface expression were shown. These immunosuppressor phenomena were also observed when the capsular polysaccharide, glucuronoxylomannan (GXM), was added to cultures of Spm cells from normal rats. However, GXM had a more pronounced effect in reducing the number of cells surviving in culture than that observed during infection and produced an increase in IL-4 production by Con-A-stimulated Spm cells. Addition of anti-IL-10 monoclonal antibody to cultures restored the lymphoproliferation of Spm cells from infected animals, indicating that IL-10 production is a suppressor mechanism of cell-mediated immunity during experimental infection. The results presented here indicate that at least two mechanisms mediate the nonspecific suppression in this model of cryptococcosis: IL-10 production and diminution of the number of T cells. GXM could be involved, since it has a pronounced effect in the reduction of Spm cells in vitro.
authors: Micología, Universidad Nacional de Córdoba, Córdoba, 5000, Argentina.
authors: L
authors: L
authors: Chiapello
authors: P
authors: P
authors: Iribarren
authors: L
authors: L
authors: Cervi
authors: H
authors: H
authors: Rubinstein
authors: D T
authors: DT
authors: Masih
mesh_terms: D000818:Animals; D003208:Concanavalin A / Q000494:pharmacology; D003453:Cryptococcosis / Q000150:complications / Q000276:immunology*; D003455:Cryptococcus neoformans / Q000737:chemistry / Q000502:physiology*; D005260:Female; D007111:Immunity, Cellular; D016753:Interleukin-10 / Q000096:biosynthesis*; D007378:Interleukins / Q000096:biosynthesis; D008213:Lymphocyte Activation / Q000187:drug effects; D016131:Lymphocyte Subsets / Q000187:drug effects / Q000276:immunology; D008231:Lymphopenia / Q000209:etiology*; D011134:Polysaccharides / Q000494:pharmacology / Q000502:physiology*; D051381:Rats; D017208:Rats, Wistar; D011948:Receptors, Antigen, T-Cell / Q000032:analysis; D013154:Spleen / Q000276:immunology
chemical_list: D007378:Interleukins; D011134:Polysaccharides; D011948:Receptors, Antigen, T-Cell; D003208:Concanavalin A; D016753:Interleukin-10; C027478:glucuronoxylomannan